Equities

Integer Holdings Corp

Integer Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)135.88
  • Today's Change2.51 / 1.88%
  • Shares traded13.00
  • 1 Year change+52.01%
  • Beta1.1053
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. It operates through Medical segment, which includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease.

  • Revenue in USD (TTM)1.68bn
  • Net income in USD114.44m
  • Incorporated1997
  • Employees10.50k
  • Location
    Integer Holdings Corp5830 Granite Parkway., Suite 1150PLANO 75024United StatesUSA
  • Phone+1 (214) 618-5243
  • Fax+1 (302) 655-5049
  • Websitehttps://integer.net
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ITGR:NYQ since
announced
Transaction
value
Pulse Technologies IncDeal completed05 Jan 202405 Jan 2024Deal completed37.87%140.00m
Data delayed at least 15 minutes, as of Nov 22 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TransMedics Group Inc401.09m32.64m2.66bn584.0084.5012.6852.796.640.93890.938911.606.250.54393.565.32686,797.904.43-16.084.78-17.9559.3465.378.14-40.477.33--0.7078--158.5379.3630.92--225.12--
Warby Parker Inc742.53m-32.56m2.80bn2.14k--8.31246.873.77-0.2731-0.27316.202.801.225.70818.21346,975.20-5.37---6.78--55.3257.49-4.39-14.532.06--0.00--11.9819.6742.75------
LivaNova PLC1.24bn23.68m2.81bn2.90k121.382.1441.372.260.42590.425922.8124.130.51192.476.42428,185.900.9777-6.011.12-7.4267.7866.991.91-13.562.872.460.3234--12.890.8278120.34---1.64--
Inari Medical Inc574.50m-78.58m2.91bn1.30k--6.69--5.07-1.35-1.359.907.440.92211.597.46441,921.50-12.61-0.5941-15.24-0.669686.8289.06-13.68-0.62951.40--0.00--28.73135.4094.41--52.46--
Neogen Corp912.20m-23.53m3.16bn2.92k--1.0133.523.46-0.1086-0.10864.2114.470.20132.715.98312,718.20-0.51931.38-0.53461.4449.5648.23-2.584.312.791.030.22150.0012.3717.4158.81--50.02--
Envista Holdings Corp2.50bn-1.34bn3.68bn12.80k--1.20--1.47-7.77-7.7714.5117.860.41064.216.19195,570.30-21.931.94-25.272.3454.2057.65-53.425.291.773.130.31630.00-0.1012-2.04-142.10---4.22--
DENTSPLY SIRONA Inc3.90bn-413.00m3.71bn15.00k--1.49--0.9501-2.07-2.0718.9112.530.56412.945.91260,000.00-5.93-1.14-7.41-1.3252.1853.65-10.51-2.510.84443.210.471--1.10-0.107186.11---4.549.86
Guardant Health Inc692.26m-512.41m3.83bn1.78k------5.53-4.24-4.245.70-0.4880.4153.687.81389,126.50-30.72-22.26-35.19-24.5960.3164.62-74.02-97.075.85-8.041.06--25.4544.1426.76--0.2786--
ICU Medical Inc2.34bn-111.01m4.12bn14.00k--2.0236.201.76-4.57-4.5796.3183.760.53912.1613.94167,149.80-2.561.46-2.901.6532.8734.11-4.742.231.030.51580.43820.00-0.915410.0460.08---1.45--
Haemonetics Corporation1.36bn123.81m4.29bn3.66k35.484.9018.393.152.412.4126.4817.440.60011.877.02372,224.005.465.026.196.0754.0251.749.108.112.0927.430.58230.0012.016.231.8716.40-11.04--
Integer Holdings Corp1.68bn114.44m4.56bn10.50k41.892.8120.602.713.243.2247.8748.330.55944.935.14160,023.803.813.284.103.5327.0626.946.816.402.094.110.40280.0016.035.6238.719.3321.71--
Procept Biorobotics Corp199.84m-100.06m5.11bn626.00--20.42--25.55-1.95-1.953.894.630.50261.833.86319,238.00-25.16---28.58--57.39---50.07--5.07--0.1758--81.55---21.51------
Inspire Medical Systems Inc755.59m33.05m5.58bn1.01k171.118.01146.817.381.091.0925.1523.251.052.469.37747,372.904.60-11.275.12-12.6084.7784.474.37-13.576.94--0.00--53.1965.3252.87--148.37--
Stevanato Group SpA1.15bn120.12m5.94bn5.64k43.863.8729.385.190.44730.44734.265.070.52842.752.66203,340.605.54--7.39--29.20--10.48--1.2148.530.2148--10.34--1.95------
Lantheus Holdings Inc1.50bn427.61m6.07bn834.0014.515.1512.394.066.026.0221.0916.970.83838.285.091,794,723.0023.956.6932.767.7364.7857.5628.579.021.56--0.3240.0038.6530.441,063.8651.8135.48--
Merit Medical Systems Inc1.33bn120.04m6.12bn6.95k51.454.6228.114.622.042.0422.5522.710.63342.297.41190,772.805.732.456.322.7746.8344.509.053.913.8231.880.36190.009.247.3326.7015.86-11.16--
Data as of Nov 22 2024. Currency figures normalised to Integer Holdings Corp's reporting currency: US Dollar USD

Institutional shareholders

54.69%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20244.92m14.65%
The Vanguard Group, Inc.as of 30 Sep 20243.74m11.15%
Dimensional Fund Advisors LPas of 30 Sep 20241.69m5.03%
SSgA Funds Management, Inc.as of 30 Sep 20241.32m3.94%
Capital Research & Management Co. (Global Investors)as of 30 Sep 20241.22m3.63%
Invesco Advisers, Inc.as of 30 Sep 20241.18m3.53%
EARNEST Partners LLCas of 30 Sep 20241.17m3.49%
Viking Global Investors LPas of 30 Sep 20241.11m3.31%
Macquarie Investment Management Business Trustas of 30 Sep 20241.02m3.04%
Fuller & Thaler Asset Management, Inc.as of 30 Sep 2024981.19k2.93%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.